Sun Pharma

Sun Pharmaceutical Industries Limited

Company type	Public
Traded as	BSE: 524715 NSE: SUNPHARMA BSE SENSEX constituent NSE NIFTY 50 constituent
ISIN	INE044A01036
Industry	Pharmaceuticals
Founded	1983; 41 years ago (1983)
Founder	Dilip Shanghvi
Headquarters	Mumbai , India
Area served	Worldwide
Key people	Dilip Shanghvi (MD)
Products	Pharmaceutical drugs generic drugs antiviral drugs over-the-counter drugs vaccines diagnostics contact lenses animal health dietary supplements protein supplements
Revenue	₹48,496 crore (US$5.8 billion) (FY24)[1]
Operating income	₹13,023 crore (US$1.6 billion) (FY24)[1]
Net income	₹9,576 crore (US$1.1 billion) (FY24)[1]
Total assets	₹85,462 crore (US$10 billion) (2024)[1]
Total equity	₹67,105 crore (US$8.0 billion) (2024)[1]
Owner	Dilip Shanghvi family (54.48%)
Number of employees	41,000+ (2023)
Website	sunpharma.com
Footnotes / references [2][3]

Sun Pharmaceutical Industries Limited (d/b/a Sun Pharma) is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering  psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals.